Concepedia

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

María P. Roberti, Yamila Rocca, Mora Amat, M. Betina Pampena, José Loza, Federico Coló, Verónica Fabiano, Carlos Martín Loza, Juan Martín Arriaga, Michele Bianchini,

Breast Cancer Research and Treatment · 2012 · 53 citations · 35 references

DOI

Concepts

References

35

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Aleix Prat, Joel S. Parker, Olga Karginova et al. · Breast Cancer Research · 2010 · 2.1K citations · Full text

, , +12

Stromal gene expression predicts clinical outcome in breast cancer

Greg Finak, Nicholas Bertos, François Pépin et al. · Nature Medicine · 2008 · 1.7K citations

, , +16

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer et al. · Journal of Clinical Oncology · 2004 · 1.7K citations · Full text

, , +16

Human NK Cell Education by Inhibitory Receptors for MHC Class I

Nicolas Anfossi, Pascale André, Sophie Guia et al. · Immunity · 2006 · 1.2K citations · Full text

, , +16

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

Émilie Mamessier, Aude Sylvain, Marie‐Laure Thibult et al. · Journal of Clinical Investigation · 2011 · 676 citations · Full text

, , +17